HUAPONT LIFE SCIENCES CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.75 CNY | +0.21% |
|
+2.37% | +1.93% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | 13.23B 1.83B | Sales 2023 | 11.59B 1.61B | Capitalization | 9.23B 1.28B |
|---|---|---|---|---|---|
| Net income 2022 | 433M 59.95M | Net income 2023 | 302M 41.81M | EV / Sales 2022 | 0.94 x |
| Net Debt 2022 | 2.36B 326M | Net Debt 2023 | 4.21B 583M | EV / Sales 2023 | 1.16 x |
| P/E ratio 2022 |
23.3
x | P/E ratio 2023 |
30.5
x | Employees | 12,476 |
| Yield 2022 |
4.31% | Yield 2023 |
-
| Free-Float | 63.24% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.21% | ||
| 1 week | +2.37% | ||
| Current month | +2.37% | ||
| 1 month | +6.03% | ||
| 3 months | +5.56% | ||
| 6 months | -0.63% | ||
| Current year | +1.93% |
1 week
4.66
4.81
1 month
4.374.81
Current year
3.784.81
1 year
3.785.32
3 years
3.789.80
5 years
3.789.80
10 years
3.7820.04
| Managers | Title | Age | Since |
|---|---|---|---|
Hai An Zhang
CEO | Chief Executive Officer | 43 | 18-09-30 |
Jian Wang
DFI | Director of Finance/CFO | 48 | 14-01-09 |
Yun Hui Peng
BRD | Director/Board Member | 60 | 01-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Song Shan Zhang
CHM | Chairman | 63 | 01-08-31 |
Yun Hui Peng
BRD | Director/Board Member | 60 | 01-08-31 |
Zhong Hai Liu
BRD | Director/Board Member | 49 | 21-08-12 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 0 M€ | +5.87% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-08 | 4.75 | +0.21% | 18,472,160 |
| 24-05-07 | 4.74 | -0.21% | 13,628,900 |
| 24-05-06 | 4.75 | +2.37% | 20,512,160 |
| 24-04-30 | 4.64 | +1.09% | 18,232,450 |
End-of-day quote Shenzhen S.E., May 07, 2024
More quotes
HUAPONT LIFE SCIENCES CO., LTD. is a China-based company principally engaged in the research and development, manufacture and sales of pesticide chemical products. The Company operates through three segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sales of skin pharmaceuticals, antituberculous pharmaceuticals and other manufactured products. Its products include fleroxacin and ambroxol hydrochloride for injection, and lecithin-bound iodine capsules, among others. The Pesticide Chemical segment is engaged in the production and sales of pesticides and other fine chemicals, including herbicides, bactericides and insecticides, among others. The Bulk Drug segment is engaged in the research and development and manufacture of bulk drugs and medical intermediates. The Company is also engaged in the provision of travel services, the sales of tea and the provision of technical services, among others.
Sector
Pharmaceuticals
Calendar
2024-05-23
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| +1.93% | 1.3B | |
| +34.34% | 698B | |
| +26.51% | 568B | |
| -4.72% | 358B | |
| +18.65% | 328B | |
| +3.79% | 283B | |
| +15.98% | 238B | |
| +6.68% | 203B | |
| -9.08% | 198B | |
| +6.56% | 165B |
- Stock Market
- Equities
- 002004 Stock